Irenic Capital Management LP Sells 163,940 Shares of Sotera Health Company $SHC

Irenic Capital Management LP lessened its stake in Sotera Health Company (NASDAQ:SHC) by 4.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,548,071 shares of the company’s stock after selling 163,940 shares during the quarter. Sotera Health comprises about 5.8% of Irenic Capital Management LP’s holdings, making the stock its largest holding. Irenic Capital Management LP’s holdings in Sotera Health were worth $55,811,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. EverSource Wealth Advisors LLC raised its stake in Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after purchasing an additional 2,935 shares during the period. Versant Capital Management Inc increased its stake in Sotera Health by 117.6% during the third quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock worth $40,000 after acquiring an additional 1,370 shares during the last quarter. Fairway Wealth LLC acquired a new stake in Sotera Health during the third quarter worth $57,000. CWM LLC raised its position in Sotera Health by 194.6% in the third quarter. CWM LLC now owns 5,191 shares of the company’s stock valued at $82,000 after purchasing an additional 3,429 shares during the period. Finally, Quadrant Capital Group LLC purchased a new stake in Sotera Health in the third quarter valued at $86,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Insider Activity at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the sale, the director directly owned 12,735,301 shares of the company’s stock, valued at approximately $194,468,046.27. This represents a 43.98% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 55.12% of the company’s stock.

Sotera Health Stock Performance

Shares of SHC opened at $13.41 on Monday. Sotera Health Company has a 1 year low of $9.53 and a 1 year high of $19.85. The stock has a market capitalization of $3.81 billion, a PE ratio of 49.67 and a beta of 1.84. The company has a debt-to-equity ratio of 3.66, a quick ratio of 2.24 and a current ratio of 2.46. The stock has a 50-day simple moving average of $17.35 and a 200-day simple moving average of $16.75.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The firm had revenue of $303.44 million for the quarter, compared to analyst estimates of $300.68 million. During the same period in the prior year, the firm earned $0.21 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. On average, analysts predict that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SHC. Piper Sandler raised Sotera Health from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $17.00 to $24.00 in a research report on Friday, January 9th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 29th. Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Citigroup upped their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Finally, Royal Bank Of Canada assumed coverage on shares of Sotera Health in a research report on Thursday, January 8th. They set an “outperform” rating and a $24.00 price objective for the company. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $20.43.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.